Sequence information
Variant position: 73 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 226 The length of the canonical sequence.
Location on the sequence:
RSRFSPQGGQRGRPHSRRRH
R TTFSPVQLEQLESAFGRNQY
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human RSRFSPQGGQRGRPHSRRRHR TTFSPVQLEQLESAFGRNQY
Gorilla RSRFSPQGGQRGRPHSRRRHR TTFSPVQLEQLESAFGRNQY
Mouse RPKLCP---QRGRPHSRRRHR TTFNPAQLEQLESAFGRNQY
Pig RPRLSPQGGQRGRPHSRRRHR TTFSPAQLEQLESAFGRNQY
Bovine RPKLSLQGVQRGRPHSRRRHR TTFSPAQLEQLESAFGRNQY
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 226
Homeobox protein prophet of Pit-1
DNA binding
69 – 128
Homeobox
Region
1 – 75
Disordered
Literature citations
Human Prop-1: cloning, mapping, genomic structure. Mutations in familial combined pituitary hormone deficiency.
Duquesnoy P.; Roy A.; Dastot F.; Ghali I.; Teinturier C.; Netchine I.; Cacheux V.; Hafez M.; Salah N.; Chaussain J.-L.; Goossens M.; Bougneres P.; Amselem S.;
FEBS Lett. 437:216-220(1998)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]; VARIANTS SER-20 AND CPHD CYS-73;
PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency.
Vallette-Kasic S.; Barlier A.; Teinturier C.; Diaz A.; Manavela M.; Berthezene F.; Bouchard P.; Chaussain J.-L.; Brauner R.; Pellegrini-Bouiller I.; Jaquet P.; Enjalbert A.; Brue T.;
J. Clin. Endocrinol. Metab. 86:4529-4535(2001)
Cited for: VARIANTS CPHD2 CYS-73 AND HIS-73;
A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies.
Reynaud R.; Chadli-Chaieb M.; Vallette-Kasic S.; Barlier A.; Sarles J.; Pellegrini-Bouiller I.; Enjalbert A.; Chaieb L.; Brue T.;
J. Clin. Endocrinol. Metab. 89:5779-5786(2004)
Cited for: VARIANT CPHD2 CYS-73; CHARACTERIZATION OF VARIANT CPHD2 CYS-73;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.